from normal variation in characteristics that may underlie or be similar to the disorder.Additional information provides a description of other features that are relevant in helping the clinician to recognize variations in presentation of the disorder, but are not diagnostically determinative.The final, published version of the guidelines will include additional information (e.g., information on features related to culture, gender and development).The WHO Department of Mental Health and Substance Abuse is interested in receiving comments on the proposed diagnostic guidelines from their intended users.To receive these comments, the Department has created a new Internet platform for members of the GCPN, called GCP.Network (http://gcp.network).This platform will make several sets of guidelines available per month until all of them are included.All mental health or primary care professionals who are legally authorized to provide services to people with mental and behavioural disorders in their countries are eligible to join the GCPN and to provide comments on the proposed diagnostic guidelines.At a later time, the draft guidelines will also be made available for review by the general public.A variety of additional resources for registered GCPN members are available at GCP.Network.These include brief reports on the results of GCPN field studies, access to articles related to the development of ICD-11 mental and behavioural disorders, and a variety of relevant training resources.We invite you to visit http://gcp.network, to register if you are not already a member, to provide comments on the proposed ICD-11 guidelines, and to take advantage of the other resources we have and will continue to develop.
No takes yet. Share an insight, caveat, or question.
Silove et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: